FDA issues early alert after BD needle set defects linked to four deaths

The FDA’s Center for Devices and Radiological Health released an early alert warning clinicians to stop using Becton Dickinson’s intraosseous vascular access needle sets after reports of serious injuries and four fatalities.

These needle sets are designed for emergency care, allowing rapid infusion of fluids and medications directly into the bone marrow of trauma patients when traditional venous access is difficult.

Becton Dickinson discovered that the devices could be difficult to withdraw after insertion, leading to complications such as improper removal of the stylet. The company issued a recall on July 30, instructing users to discontinue use immediately and to destroy or quarantine any affected inventory.